PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Diagnostics

Background:

• Previous Affymetrix array analysis indicated PINCH-2 gene overexpression in malignant mesothelioma.
• This overexpression was noted in comparison to ovarian/peritoneal serous carcinoma.

Purpose of the Study:

• To validate the overexpression of PINCH-2 at both mRNA and protein levels.
• To assess the diagnostic utility of PINCH-2 in differentiating mesothelioma from other carcinomas.

Main Methods:

• Quantitative PCR was used to measure PINCH-2 mRNA expression in 91 effusion samples (mesothelioma, ovarian, and breast carcinomas).
• Flow cytometry analyzed PINCH-2 protein expression in 37 of these effusions.

Main Results:

• Malignant mesotheliomas exhibited significantly higher PINCH-2 mRNA levels than carcinomas (P = 0.004).
• Low PINCH-2 mRNA (<10 copies) was exclusively found in carcinoma effusions (25.4% ovarian, 50% breast).
• PINCH-2 protein expression showed no significant difference across the three cancer types and did not correlate with survival or other molecular markers in ovarian carcinoma.

Conclusions:

• PINCH-2 mRNA overexpression is characteristic of malignant mesothelioma in serosal cavities compared to carcinomas.
• Low PINCH-2 mRNA levels can aid in excluding a mesothelioma diagnosis.
• Consistent PINCH-2 protein expression across studied cancers suggests a potential role in effusion-based cancer biology, warranting further investigation.